These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10092105)
1. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105 [TBL] [Abstract][Full Text] [Related]
2. Upregulation and spatial shift in the localization of the mannose 6-phosphate/insulin-like growth factor II receptor during radiation enteropathy development in the rat. Wang J; Richter KK; Sung CC; Hauer-Jensen M Radiother Oncol; 1999 Feb; 50(2):205-13. PubMed ID: 10368045 [TBL] [Abstract][Full Text] [Related]
3. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Ghahary A; Tredget EE; Mi L; Yang L Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576 [TBL] [Abstract][Full Text] [Related]
4. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. Leksa V; Godar S; Schiller HB; Fuertbauer E; Muhammad A; Slezakova K; Horejsi V; Steinlein P; Weidle UH; Binder BR; Stockinger H J Cell Sci; 2005 Oct; 118(Pt 19):4577-86. PubMed ID: 16179614 [TBL] [Abstract][Full Text] [Related]
6. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. Odekon LE; Blasi F; Rifkin DB J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064 [TBL] [Abstract][Full Text] [Related]
13. Characterization of latent TGF-beta activation by murine peritoneal macrophages. Nunes I; Shapiro RL; Rifkin DB J Immunol; 1995 Aug; 155(3):1450-9. PubMed ID: 7636210 [TBL] [Abstract][Full Text] [Related]
14. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells. Leksa V; Schiller HB; Stockinger H Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis. Melnick M; Chen H; Buckley S; Warburton D; Jaskoll T Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403 [TBL] [Abstract][Full Text] [Related]
17. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings. Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255 [TBL] [Abstract][Full Text] [Related]
18. Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Ghahary A; Tredget EE; Shen Q; Kilani RT; Scott PG; Houle Y Growth Factors; 2000; 17(3):167-76. PubMed ID: 10705575 [TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157 [TBL] [Abstract][Full Text] [Related]